Noile-Immune Biotech Inc. (TYO:4893)
Japan · Delayed Price · Currency is JPY 150.00
-1.00 (-0.66%)
Apr 17, 2026, 3:30 PM JST
Noile-Immune Biotech Market Cap
Noile-Immune Biotech has a market cap or net worth of 6.5 billion as of April 17, 2026. Its market cap has decreased by -10.71% in one year.
Market Cap
6.50B
Enterprise Value
2.58B
Revenue
5.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
150.00
Market Cap Chart
Since June 28, 2023, Noile-Immune Biotech's market cap has decreased from 30.89B to 6.50B, a decrease of -78.97%. That is a compound annual growth rate of -42.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 6.50B | 12.78% |
| Dec 30, 2025 | 5.76B | -21.76% |
| Dec 30, 2024 | 7.36B | -19.77% |
| Dec 29, 2023 | 9.17B | -70.30% |
| Jun 28, 2023 | 30.89B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 8.03B |
| Carna Biosciences | 8.00B |
| MEDINET | 7.99B |
| CellSource | 7.76B |
| ADR120S | 7.37B |
| Chiome Bioscience | 7.30B |
| PRISM BioLab Co.,LTD | 7.17B |
| Kohjin Bio | 6.96B |